Matrix adhering to nasal mucosa
AssigneeTakeda Chemical Industries, Ltd.
InventorsYoko Akiyama, Naoki Nagahara, Hiroto Bando
Life of this patent
Estimating the term…
Abstract
This invention provides a matrix adhering to the nasal mucosa which allows improved transfer into the brain of a drug exerting its effect in the brain and is capable of continuously supplying the drug into the brain. This matrix contains a polyglycerol fatty acid ester, the drug exerting its effect in the brain, and a viscogenic substance.
Claims2
A matrix adhering to the nasal mucosa which allows improved transfer into the brain of a drug exerting its effect in the brain, which comprises a polyglycerol fatty acid ester, the drug exerting its effect in the brain, and a viscogenic substance, wherein the drug exerting its effect in the brain is (S)-N-[2-(1,6,7,8-tetrahydro-2H-indeno [5,4-b]furan-8-yl)ethyl] propionamide.
A matrix adhering to the nasal mucosa which allows improved transfer into the brain of a drug exerting its effect in the brain, which comprises a polyglycerol fatty acid ester, the drug exerting its effect in the brain, and a viscogenic substance, wherein the drug exerting its effect in the brain is (S)-N-[2-(1,6,7,8-tetrahydro-2H-indeno [5,4-b]furan-8-yl)ethyl] acetamide.
Dependencies are inferred from the claim text.